Microbiome Research: Past, Present, and Future

Dear Colleagues,

At the turn of the century, the human genome was sequenced, which was hailed as a breakthrough. Experts thought that this milestone would lead to answers for many key questions in human health; researchers believed that the complete DNA sequence would help pinpoint the causes of diseases and revolutionize medicine. However, it was not long before the scientific community began seeking answers from another frontier: the human microbiome. 

With advances in high-throughput technologies, scientists are aiming to explore the complex host–microbe interactions that influence conditions such as obesity, autoimmune disorders, and mental health. Despite considerable efforts, the search for these answers has faced numerous challenges. Along the way, many studies have focused on identifying specific microbes associated with health and disease, often overlooking the functional redundancy between any two microbes.

The quest to define healthy microbiomes has gained some traction in the context of clear functional requirements; for example, the microbiomes of healthy infants must include molecular activities that enable the digestion of human milk oligosaccharides. In the same vein, researchers have come to recognize that long-term health is shaped not only by specific microbes but by the collective interactions in the microbiota and that the microbiome influences the human body in many ways.

Current estimates suggest that, including metagenome-assembled genomes, only 50% of the human microbiome has been sequenced, with an even smaller fraction of microbial functional activities having been fully characterized. Significant gaps remain in our understanding of these uncharacterized species and molecular activities, including their roles in health and disease.

For this Special Issue, we invite original research articles, perspectives, mini-reviews, commentaries, and opinion papers that contribute toward advancing these critical areas.

Dr. Eric Patridge
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• human microbiome
• high-throughput technologies
• host–microbe interactions
• disease and health
• gene expression/metatranscriptomics
• functional genomics/orthologs
• bioinformatics advances in microbial research
• new bacterial pathogens/virulence factors
• microbial dysbiosis/homeostasis